# Influence of Hormone Treatment in Radiation Therapy for Bladder Cancer

> **NCT04282876** · — · UNKNOWN · sponsor: **Aarhus University Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Bladder Cancer
- Radiation Therapy Complication
- Quality of Life

## Interventions

- **DRUG:** Degarelix

## Key facts

- **NCT ID:** NCT04282876
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-19
- **Primary completion:** 2024-02-01
- **Final completion:** 2025-10-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04282876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04282876, "Influence of Hormone Treatment in Radiation Therapy for Bladder Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04282876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*